Novartis Hid Manipulated Data While Seeking Approval for $2.1 Million Treatment. Novartis AG, Falsification of Data, Clinical Trials, Food and Drug Administration, Drugs (Pharmaceuticals), Genetic Engineering, Spinal Muscular Atrophy, Fines (Penalties), your-feed-healthcare